Dong Ha Kim

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

High Throughput

Anti Inflammatory

Tyrosine Kinase

Brain Metastases

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yun Jung Choi, Da-Som Kim, Young Hoon Sung, Dong Ha Kim, Kyungtaek Im, Hyeonjeong Lee, Chae Won Lee, Jeongin Cho, Joongkee Min, Dong-Cheol Woo, Sung-Eun Kim, Sunho Lee, Yun Jeong Kong, Hyung Chul Ryu, Jae-Sun Kim, Rajesh Rengasamy, Wonjun Ji, Chang-Min Choi, Jae Cheol Lee, Jin Kyung Rho
The reversible fourth-generation EGFR tyrosine kinase inhibitor OBX02-011 overcomes C797S-mediated resistance in lung cancer. Cancer research (2022)